Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicity-Reference-Cited by-同舟云学术

Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicity

Published:2018-12-10 Issue:1 Volume:129 Page:349-363
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Pai Chien-Chun Steven,Simons Donald M.,Lu Xiaoqing,Evans Michael,Wei Junnian^ORCID,Wang Yung-hua,Chen Mingyi,Huang John,Park Chanhyuk,Chang Anthony^ORCID,Wang Jiaxi,Westmoreland Susan,Beam Christine,Banach Dave,Bowley Diana,Dong Feng,Seagal Jane,Ritacco Wendy,Richardson Paul L.,Mitra Soumya,Lynch Grace,Bousquet Pete,Mankovich John,Kingsbury Gillian,Fong Lawrence

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/123391/files/pdf

Reference49 articles.

1. CTLA-4 blockade in tumor models: an overview of preclinical and translational research;Grosso;Cancer Immun,2013

2. PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

3. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

4. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

5. Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple omics integrative analysis identifies GARS1 as a novel prognostic and immunological biomarker: from pan-cancer to bladder cancer;Scientific Reports;2024-08-16

2. Targeting cytotoxic lymphocyte antigen 4 (CTLA-4) in breast cancer;European Journal of Medical Research;2024-07-02

3. CD155-TIGIT Axis as a Therapeutic Target for Cancer Immunotherapy;Current Medicinal Chemistry;2024-04

4. The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling;Cell Communication and Signaling;2024-03-12

5. Comprehensive multi-omics analysis and experimental verification reveal PFDN5 is a novel prognostic and therapeutic biomarker for gastric cancer;Genomics;2024-03